medRxiv
Safety and Exploratory Efficacy of Reduced β-Nicotinamide Mononucleotide Calcium Salt (NMNH-Ca) in Healthy Middle-Aged and Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial
Preprint: randomised trial in 80 peopleInterventions
90 days, double-blind, placebo-controlled, dose-response
- Reduced nicotinamide mononucleotide calcium salt
- NAD+ metabolism
- NAD+
- Phenotypic Age
- Whole-blood NAD
- Humans
The paper
Ltd; Stanford Medicine
medRxiv, 14 Aug 2026, Preprint, not peer-reviewed
